Bladder Cancer | PharmaShots

AstraZeneca Reports Results of Imfinzi and Tremelimumab in P-III DANUBE Study for Unresectable Stage IV Bladder Cancer

March 6, 2020March 6, 2020Tuba Khan

Shots: The P-III DANUBE study involves assessing Imfinzi as monothx. & Imfinzi + Tremelimumab vs SOC CT as a 1L treatment for patients [Read More...]

Ferring and Blackstone Collaborate to Establish Joint Venture Focusing on Developing Gene Therapy for Bladder Cancer

Ferring and Blackstone Collaborate to Establish Joint Venture Focusing on the Development of Gene Therapy for Bladder Cancer

November 26, 2019November 26, 2019Tuba Khan

Shots: Ferring launches a new company FerGene focusing the global development and commercialization of Nadofaragene firadenovec in the US for the patients with [Read More...]

Roche Reports Results of Tecentriq in P-III IMvigor130 Study for Previously Untreated Advanced Bladder Cancer

August 5, 2019August 5, 2019Tuba Khan

Shots: The P-III IMvigor130 study involves assessing of Tecentriq + platinum-based CT vs platinum based-CT as monothx. in 1213 patients with metastatic urothelial [Read More...]

SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer

July 5, 2019July 5, 2019Tuba Khan

Shots: The machine learning model utilizes MLP (multi-layer perceptron) software, providing a non-invasive diagnostic option, analyzes a patient’s metabolites and their chemical descriptors, [Read More...]